Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

A new potential therapy for Alzheimer's disease

A new potential therapeutic target for Alzheimer’s disease has been discovered by US researchers based at Case Western Reserve University.

4 Dec 2020

Study details the impacts of ocean pollution on human health

Ocean pollution is widespread and getting worse, and when toxins in the oceans make landfall they imperil the health and well-being of more than 3 billion people, according to a new report by an international coalition of scientists led by Boston College's Global Observatory on Pollution on Health and the Centre Scientifique de Monaco, supported by the Prince Albert II of Monaco Foundation.

3 Dec 2020

Experts address the global burden of brain diseases

Think Brain Health - a policy, clinical and research challenge, a virtual meeting featuring expert speakers in the field of neurodegenerative diseases, addressed current and future opportunities to help everyone achieve good brain health.

3 Dec 2020

Study provides new insights into an untreatable form of childhood-onset dementia

Is the eye a window to the brain in Sanfilippo syndrome, an untreatable form of childhood-onset dementia, Australian researchers ask in a new publication.

2 Dec 2020

POSTECH researchers solve the enigma to treating neurological diseases

Neurological diseases of the brain such as dementia, autism and schizophrenia are now a growing social problem. Nevertheless, studies on their definitive cause are still insufficient.

2 Dec 2020

Study highlights pros and cons of AI-based apps used to benefit older adults

A new analysis from North Carolina State University highlights the realistic pros and cons of apps and other technologies that use artificial intelligence (AI) to benefit older adults, including those facing dementia and cognitive decline.

2 Dec 2020

Three leading organizations join hands to address global challenges in dementia

To address the growing public health crisis of dementia, three leading organizations announced funding for 23 small-scale pilot projects as part of this year's Pilot Awards for Global Brain Health Leaders.

1 Dec 2020

Study may help to better understand the pathological process involved in brain diseases

A team of researchers at the Case Western Reserve University School of Medicine has taken a major step toward understanding the mechanisms involved in the formation of large clumps of tau protein, a hallmark of Alzheimer's disease and several other neurodegenerative disorders.

1 Dec 2020

Older adults may be coping with COVID-19's mental health effects better than other age groups

Older adults are especially vulnerable to the effects of the COVID-19 pandemic--with higher risks of severe complications and death, and potentially greater difficulties accessing care and adapting to technologies such as telemedicine.

1 Dec 2020

Experimental drug can reverse age-related memory decline in mice

Just a few doses of an experimental drug can reverse age-related declines in memory and mental flexibility in mice, according to a new study by UC San Francisco scientists.

1 Dec 2020

Children with dyslexia show higher emotional reactivity

Children diagnosed with dyslexia show greater emotional reactivity than children without dyslexia, according to a new collaborative study by UC San Francisco neuroscientists with the UCSF Dyslexia Center and UCSF Memory and Aging Center.

1 Dec 2020

FAU receives $675,000 grant to improve social engagement in older population

Vibrant social relationships are a critical component of healthy aging. Strong relationships provide emotional support and well-being, promote brain health, and can even slow the progression of neurodegenerative diseases.

1 Dec 2020

Researchers report AI solution that could revolutionize medical research

Inside every cell, thousands of different proteins from the machinery that keeps all living things - from humans and plants to microscopic bacteria - alive and well. Almost all diseases, including cancer, dementia, and even infectious diseases such as COVID-19, are related to the way these proteins function.

1 Dec 2020

Financial symptoms could be used as early predictors of dementia

A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health and the Federal Reserve Board of Governors found that Medicare beneficiaries who go on to be diagnosed with dementia are more likely to miss payments on bills as early as six years before a clinical diagnosis.

30 Nov 2020

New effort to increase COVID-19 testing in Louisiana's Black communities

Pennington Biomedical Research Center is leading a federally funded effort to increase COVID-19 testing in Louisiana's Black communities, which have been hit hard by the virus.

30 Nov 2020

Validated biomarkers can reveal individual’s risk of developing Alzheimer’s

A new study from Lund University in Sweden shows that validated biomarkers can reveal an individual's risk of developing Alzheimer's disease.

30 Nov 2020

Machine learning model uses retinal scans to detect Alzheimer’s disease

A form of artificial intelligence designed to interpret a combination of retinal images was able to successfully identify a group of patients who were known to have Alzheimer's disease, suggesting the approach could one day be used as a predictive tool, according to an interdisciplinary study from Duke University.

30 Nov 2020

Scientists develop new tools to detect very early changes in Alzheimer’s disease

Researchers at the University of Gothenburg in Sweden, together with their colleagues at the Barcelona Beta Research Centre in Spain, the University Medical Centre in Ljubljana, Slovenia, and the University of Paris, have found new forms of tau protein that become abnormal in the very early stages of Alzheimer's disease before cognitive problems develop.

30 Nov 2020

Prolonged education may not have a protective effect against dementia

The state of knowledge seemed clear: school education protects against dementia. Every school year is supposed to reduce the risk of developing dementia in later life by up to seven percent.

26 Nov 2020

Biocompatible photooxygenation catalyst could be potentially used to treat amyloid diseases

A new, biocompatible photooxygenation catalyst that can selectively oxygenate and degrade the pathogenic aggregation of Alzheimer's disease (AD)-related amyloid-β peptide (Aβ) under near-infrared (NIR) light irradiation is developed.

25 Nov 2020